Hasil Pencarian  ::  Simpan CSV :: Kembali

"Tujuan dari penelitian ini adalah untuk mengetahui pengaruh dukungan atasan dan trait competitiveness terhadap self-efficacy dan work engagement karyawan di rumah sakit kusta Dr. Sitanala Tangerang. Dari hasil data dan pengujian hipotesis yang menggunakan uji analisis SEM, diperoleh hasil bahwa dukungan atasan dan trait competitiveness secara signifikan berpengaruh positif terhadap self-efficacy dan work engagement yang terdiri dari vigor, dedication dan absorption. Self-efficacy secara signifikan berpengaruh negatif terhadap dimensi work engagement yang terdiri dari vigor, dedication, dan absorption. Metode penelitian ini menggunakan kuantitatif eksplorasi. Teknik pengambilan sampel menggunakan stratified sampling proporsional. Pengumpulan data yang digunakan dalam penelitian ini menyebarkan kuesioner ke setiap divisi yang telah ditetapkan jumlah sampelnya. Peneliti menyarankan agar RSK. Dr. Sitanala Tangerang menciptakan budaya pembelajaran dalam organisasi yang bersifat terbuka, memberikan penghargaan kepada karyawan yang memiliki prestasi, semangat dan dedikasi dalam pekerjaan dan meningkatkan dukungan atasan melalui pelatihan mentoring dan coaching.

---

The purpose of this research is to examine the effect supervisor support and trait competitiveness on self-efficacy and work engagement employee at leprosy hospital Dr. Sitanala Tangerang. From the results of the data and hypothesis testing using SEM analysis, obtained the result that supervisor support and trait competitiveness significant positive impact on self-efficacy and work engagement consists of vigor, dedication and absorption. At self-efficacy variable significant negative on work engagement consists of vigor, dedication and absorption. This research is quantitative eksplanative. Sampling technique using proporsional stratified sampling. Data collection methods used in this study go round each division through the questionnaire. The researcher suggests that creating a learning culture in the organization is open, give awards to employees who have the achievements, spirit and dedication in their work and enhance employer support through mentoring and coaching training."

"Kebersihan tangan dapat mencegah Health Care Associated Infections (HAIs) dan meningkatkan keselamatan pasien. Penggunaan fluorescence lotion pada pelatihan kebersihan tangan merupakan metode pembelajaran dengan menggunakan experiential learning yang bertujuan untuk meningkatkan pengetahuan dan kepatuhan perawat dalam kebersihan tangan. Tujuan untuk mengidentifikasi pengaruh program pelatihan kebersihan tangan terhadap pengetahuan dan kepatuhan perawat dalam kebersihan tangan. Rancangan penelitian adalah penelitian kuantitatif dengan pendekatan quasy experiment dengan metode pretestposttest designs with comparison group. Sampel dalam penelitian adalah 32 perawat pelaksana untuk kelompok intervensi dan 38 perawat pelaksana untuk kelompok kontrol. Ada perbedaan pengetahuan dan kepatuhan kebersihan tangan antara kelompok eksperimen dan kelompok kontrol setelah pelatihan kebersihan tangan (p<0,001, CI pengetahuan = 2,061 ; 3,541, CI kepatuhan = 6,792 ; 10,929, α = 0.05). Pelatihan kebersihan tangan perlu dilakukan berkesinambungan.

---

Hand hygiene prevents Health-Care-Associated Infections (HAIs) and improves patient safety. The use of fluorescence lotion in hand hygiene training is the implementation of a learning method which makes use of experiential learning aiming at improving the level of knowledge and compliance of nurses in maintaining hand hygiene. The research objective is to identify the influence of hand hygiene training program on the level of knowledge and compliance of nurses in maintaining hand hygiene. The research is a quantitative quasy experiment research using pretest-posttest design with comparison group. The research sample consists of 32 nurses in experiment group and 38 nurses in control group. The result shows a difference in the knowledge after hand hygiene training was conducted (p<0.001 , CI knowledge = 2,061 ; 3,541, CI compliance = 6,792 ; 10,929, α = 0.05α = 0.05) between those in the control group and those in the experiment group. It is recommended to sustainably conduct hand hygiene training program."

"ABSTRAKDiabetes mellitus tipe 2 DMT2 adalah suatu kondisi ketika sel tubuh resisten terhadap insulin yang dihasilkan oleh sel ? pankreas. World Health Organization WHO memperkirakan prevalensi penderita DMT2 akan terus meningkat terutama di negara-negara berkembang termasuk Indonesia. Pengobatan diabetes jangka panjang, pola peresepan yang beragam dan perbedaan harga insulin dibandingkan sulfonilurea dan biaguanid menyebabkan perbedaan biaya yang dikeluarkan untuk terapi. Penelitian merupakan analitik deskriptif dengan desain cross sectional.Penelitian dilakukan untuk mengetahui efektivitas pengobatan dan efisiensi biaya antidiabetes pada pasien DMT2 rawat jalan di RSK Dr. Sitanala Tangerang pada periode April 2015 - Juni 2015 yang mengkomsumsi obat yang sama selama 4 bulan terakhir. Subjek penelitian dibagi menjadi tiga kelompok yaitu yang menggunakan insulin n=29 , yang menggunakan obat sulfonilurea n=29 dan yang menggunakan kombinasi sulfonilura-biguanid n=39 .Efektivitas pengobatan dilihat dari nilai HbA1c pasien dan analisis antidiabetes dari segi efektivitas pengobatan dan biaya dilakukan dengan menggunakan Cost Effectiveness Analysis CEA . Hasil penelitian menunjukkan bahwa pasien DMT2 berjenis kelamin perempuan lebih banyak dibandingkan pasien laki-laki yaitu 68 orang 65,96 dengan rata-rata usia pasien DMT2 yaitu 50-59 tahun. Efektivitas tertinggi dihasilkan oleh kombinasi sulfonilurea-biguanid yaitu 7,48 1,89. Nilai ACER Average cost effectiveness ratio kelompok insulin adalah Rp. 40.866, kelompok sulfonilurea adalah Rp. 1.369 dan kelompok kombinasi sulfonilurea-biguanid adalah Rp. 2.621. Nilai ICER incremental cost effectiveness ratio untuk terapi sulfonilurea-biguanid terhadap terapi sulfonilurea adalah Rp. 16.194. Berdasarkan analisis yang dilakukan, terapi kombinasi sulfonilurea-biguanid lebih cost effective dibandingkan terapi insulin ataupun terapi sulfonilurea tunggal.

---

ABSTRACTType 2 diabetes mellitus T2DM is a condition when the body cells are resistant to insulin produced by the pancreas cells. World Health Organization WHO estimates that the prevalence of type 2 diabetes will continue to increase, especially in developing countries, including Indonesia. Long term diabetes treatment, prescribing pattern varied and the price difference compared to sulfonylurea insulin and biaguanid cause differences in costs incurred for treatment. The research is descriptive analytic with cross sectional design.The study was conducted to examine the effectiveness and cost efficiency antidiabetic treatment in patients with type 2 diabetes outpatient Dr. Sitanala Leprosy Hospital in Tangerang in the period April 2015 June 2015 were consuming the same drug during the last 4 months. Subjects were divided into three groups who use insulin n 29 , which uses a sulfonylurea drug n 29 and those using sulfonilura biguanide combination n 39 .The effectiveness of treatment views of HbA1c values of patients and analysis of antidiabetic terms of the effectiveness of treatment and the cost is done by using the Cost Effectiveness Analysis CEA . Results showed that patients with type 2 diabetes were female more than male patients ie 68 65.96 with an average age of patients with type 2 diabetes that is 50 59 years. The highest effectiveness generated by the combination of sulfonylurea biguanide is 7.48 1.89. Value ACER Average cost effectiveness ratio insulin group is Rp. 40 866, sulfonylurea group is Rp. 1369 and the combination of sulfonylurea biguanide group is Rp. 2,621. Value ICER incremental cost effectiveness ratio for the treatment of sulfonylurea biguanide to sulfonylurea therapy is Rp. 16 194. Based on the analysis performed, sulfonylurea biguanide combination therapy is more cost effective than sulfonylurea insulin therapy or single therapy."

"Peran wanita saat ini semakin luas, karena tidak hanya bertanggungjawab dalam keluarga, namun juga turut berperan aktif dalam bekerja. Perencanaan untuk memiliki peran yang seimbang antara keduanya tidak lepas dari antisipasi munculnya konflik antar peran atau yang disebut dengan antisipasi konflik kerja-keluarga. Penelitian ini bertujuan untuk melihat efek trait kepribadian dan self efficacy work-family conflict terhadap antisipasi konflik kerja-keluarga pada wanita. Penelitian nonexperimental ini menggunakan anticipated work-family conflict scale untuk mengukur AWFC, Big Five Inventory untuk mengukur trait kepribadian dan work-family conflict self efficacy scale untuk mengukur work-family conflict self efficacy. Partisipan penelitian ini sebanyak 148 orang wanita pada tahap emerging adulthood M = 20.10, SD = 1.551 yang belum bekerja dan berumah tangga. Hasil yang didapatkan berdasarkan analisis mulitple regression menunjukkan bahwa trait conscientiousnessberperan terhadap time based anticipated family interfere work, trait neuroticismberperan terhadap strain based anticipated work interfere family/ family interfere work dan trait agreeablenessberperan terhadap behavior based anticipated family interfere work. Tidak ditemukan pengaruh dari self efficacy terhadap anticipated work-family conflict. Adapun trait kepribadian memiliki kontribusi yang lebih besar dibandingkan self efficacy work-family conflict.

---

Women rsquo s role is increasing on our society, which is not only responsible in their family as housewife but they also play an active role as a worker. Have balanced life between the two role can rsquo t be separated from the expectation that there will be conflict emerged between roles, which called anticipated work family conflict. This study aims to see the effect of personality trait and self efficacy on anticipated work family conflict among women. This study is nonexperimental study that used Anticipated Work Family Conflict Scale, Big Five Inventory BFI and Work Family Conflict Self Efficacy. Based on women N 148 in their emerging adulthood M 20.10, SD 1.551 , current paper found that conscientiousness significantly predicted time based anticipated family interfere work, neuroticism predicted strain based anticipated work interfere family family interfere work, and agreeableness predicted behavior based anticipated family interfere work. There was no role of self efficacy on anticipated work family conflict. In general, personality trait contributed extensively on anticipated work family conflict more than self efficacy."

"[ABSTRAK Penelitian mengenai efektivitas pengobatan diabetes melitus dan kaitannyadengan pencegahan komplikasi masih menujukkan hasil yang beragam. Penelitianini bertujuan untuk membandingkan efektivitas hipoglikemik dan fungsi ginjaldari sulfonilurea, kombinasi sulfonilurea dan biguanid serta injeksi insulin. Disainpenelitian adalah kohort retrospektif pada pasien diabetes melitus tipe 2 rawatjalan yang mengkonsumsi obat yang sama selama empat bulan terakhir di RSKDr. Sitanala Tangerang. Penelitian ini dilaksanakan pada kurun waktu April-Juni2015, dan sudah mendapatkan lulus kaji etik dari Komite Etik rumah sakit ini.Subyek penelitian dibagi kedalam tiga kelompok yaitu yang menggunakan injeksiinsulin (n = 30), yang menggunakan obat sulfonilurea tunggal (n = 30), dankombinasi sulfonilurea dan biguanid (n = 45). Efektivitas hipoglikemik dilihatdari nilai HbA1C pasien dan komplikasi nefropati diabetik dilihat dari nilai eLFGyang dihitung dari angka serum kreatinin. Rerata usia keseluruhan pasien adalah54,98±7,47, sebagian besar adalah wanita (72%) dan cenderung overweight(rerata IMT 25,47±4,77). Ada perbedaan yang bermakna (p = 0,042 ) pada nilaiHbA1C pasien kelompok kombinasi sulfonilurea-biguanid (rerata HbA1C7,28±0,09) dibandingkan dengan kelompok insulin (rerata HbA1C 8,10±0,09),sementara dengan kelompok sulfonilurea tunggal tidak ada perbedaan yangbermakna. Sedangkan nilai eLFG untuk setiap kelompok obat tidak ditemukanperbedaan yang bermakna. Subyek yang memiliki riwayat diabetes melitus dalamkeluarga mempunyai peluang 4,512 kali (interval kepercayaan 95%, p = 0,010)lebih besar dibandingkan dengan yang tidak memiliki riwayat diabetes dalamkeluarga untuk memiliki nilai HbA1C lebih dari 7%. Pasien dengan IMT >30kg/m2 mempunyai peluang sebesar 21,631 (p = 0,012) dibandingkan pasiendengan IMT < 18,5 kg/m2 untuk memiliki nilai HbA1C yang tidak terkontrol ataudiatas 7%. Pengobatan dengan kombinasi antidiabetik oral sulfonilurea danbiguanid lebih efektif dalam menurunkan nilai HbA1C pasien DM tipe 2dibandingkan dengan insulin atau sulfonilurea tunggal, dan tidak ada perubahanbermakna dalam penurunan fungsi ginjal ABSTRACT Research on effectiveness of therapy on diabetes mellitus associated with

prevention of its complication still remain varied in results. The hypoglycemic

effectiveness and the kidney function were compared between sulfonylurea,

sulfonylurea and biguanide combination and insulin, with the retrospective cohort

study design, on patients that use those agents in last four months and came to

out-patient clinic of RSK Dr. Sitanala Tangerang. This research had the Ethical

Clearance from the Ethical Committee of this hospital. Subjects were classify into

three groups, i.e insulin group (n = 30), sulfonylurea group (n = 30) and

sulfonylurea and biguanide combination group (n = 45). Hypoglycemic

effectiveness is measured with the HbA1C level and diabetic nephrophaty with

the eGFR which calculated from the measured serum creatinin. Mean age of all

subjects was 54,98±7,47 (p=0,157), most were women (72%, p=0,235), and tend

to overweight (mean BMI is 25,49±4,84; p = 0,59). Mean HbA1C level from the

sulfonylurea-biguanide (7,28±0,09) group were significantly different (p = 0,042)

with those from the insulin group (8,10±0,09), and there was no significant

difference with the sulfonylurea group. There was no significant difference in

diabetic nephropathy between groups. Subject with diabetic family history has

4,512 times chance to have the HbA1C level > 7% compare to those without

diabetic family history. Subjects with BMI >30 kg/m2 have 21,631 times chance

to get the HbA1C >7% compare to subjects with BMI <18,5 kg/m2. Sulfonylurea

and biguanide combination was more effective compare to insulin or sulfonylurea

monotherapy on decreasing HbA1C level of type 2 DM patients, without

significant difference in effect of lowering kidney functionH;Research on effectiveness of therapy on diabetes mellitus associated with

prevention of its complication still remain varied in results. The hypoglycemic

effectiveness and the kidney function were compared between sulfonylurea,

sulfonylurea and biguanide combination and insulin, with the retrospective cohort

study design, on patients that use those agents in last four months and came to

out-patient clinic of RSK Dr. Sitanala Tangerang. This research had the Ethical

Clearance from the Ethical Committee of this hospital. Subjects were classify into

three groups, i.e insulin group (n = 30), sulfonylurea group (n = 30) and

sulfonylurea and biguanide combination group (n = 45). Hypoglycemic

effectiveness is measured with the HbA1C level and diabetic nephrophaty with

the eGFR which calculated from the measured serum creatinin. Mean age of all

subjects was 54,98±7,47 (p=0,157), most were women (72%, p=0,235), and tend

to overweight (mean BMI is 25,49±4,84; p = 0,59). Mean HbA1C level from the

sulfonylurea-biguanide (7,28±0,09) group were significantly different (p = 0,042)

with those from the insulin group (8,10±0,09), and there was no significant

difference with the sulfonylurea group. There was no significant difference in

diabetic nephropathy between groups. Subject with diabetic family history has

4,512 times chance to have the HbA1C level > 7% compare to those without

diabetic family history. Subjects with BMI >30 kg/m2 have 21,631 times chance

to get the HbA1C >7% compare to subjects with BMI <18,5 kg/m2. Sulfonylurea

and biguanide combination was more effective compare to insulin or sulfonylurea

monotherapy on decreasing HbA1C level of type 2 DM patients, without

significant difference in effect of lowering kidney functionH;Research on effectiveness of therapy on diabetes mellitus associated with

prevention of its complication still remain varied in results. The hypoglycemic

effectiveness and the kidney function were compared between sulfonylurea,

sulfonylurea and biguanide combination and insulin, with the retrospective cohort

study design, on patients that use those agents in last four months and came to

out-patient clinic of RSK Dr. Sitanala Tangerang. This research had the Ethical

Clearance from the Ethical Committee of this hospital. Subjects were classify into

three groups, i.e insulin group (n = 30), sulfonylurea group (n = 30) and

sulfonylurea and biguanide combination group (n = 45). Hypoglycemic

effectiveness is measured with the HbA1C level and diabetic nephrophaty with

the eGFR which calculated from the measured serum creatinin. Mean age of all

subjects was 54,98±7,47 (p=0,157), most were women (72%, p=0,235), and tend

to overweight (mean BMI is 25,49±4,84; p = 0,59). Mean HbA1C level from the

sulfonylurea-biguanide (7,28±0,09) group were significantly different (p = 0,042)

with those from the insulin group (8,10±0,09), and there was no significant

difference with the sulfonylurea group. There was no significant difference in

diabetic nephropathy between groups. Subject with diabetic family history has

4,512 times chance to have the HbA1C level > 7% compare to those without

diabetic family history. Subjects with BMI >30 kg/m2 have 21,631 times chance

to get the HbA1C >7% compare to subjects with BMI <18,5 kg/m2. Sulfonylurea

and biguanide combination was more effective compare to insulin or sulfonylurea

monotherapy on decreasing HbA1C level of type 2 DM patients, without

significant difference in effect of lowering kidney functionH;Research on effectiveness of therapy on diabetes mellitus associated with

prevention of its complication still remain varied in results. The hypoglycemic

effectiveness and the kidney function were compared between sulfonylurea,

sulfonylurea and biguanide combination and insulin, with the retrospective cohort

study design, on patients that use those agents in last four months and came to

out-patient clinic of RSK Dr. Sitanala Tangerang. This research had the Ethical

Clearance from the Ethical Committee of this hospital. Subjects were classify into

three groups, i.e insulin group (n = 30), sulfonylurea group (n = 30) and

sulfonylurea and biguanide combination group (n = 45). Hypoglycemic

effectiveness is measured with the HbA1C level and diabetic nephrophaty with

the eGFR which calculated from the measured serum creatinin. Mean age of all

subjects was 54,98±7,47 (p=0,157), most were women (72%, p=0,235), and tend

to overweight (mean BMI is 25,49±4,84; p = 0,59). Mean HbA1C level from the

sulfonylurea-biguanide (7,28±0,09) group were significantly different (p = 0,042)

with those from the insulin group (8,10±0,09), and there was no significant

difference with the sulfonylurea group. There was no significant difference in

diabetic nephropathy between groups. Subject with diabetic family history has

4,512 times chance to have the HbA1C level > 7% compare to those without

diabetic family history. Subjects with BMI >30 kg/m2 have 21,631 times chance

to get the HbA1C >7% compare to subjects with BMI <18,5 kg/m2. Sulfonylurea

and biguanide combination was more effective compare to insulin or sulfonylurea

monotherapy on decreasing HbA1C level of type 2 DM patients, without

significant difference in effect of lowering kidney functionH, Research on effectiveness of therapy on diabetes mellitus associated with

prevention of its complication still remain varied in results. The hypoglycemic

effectiveness and the kidney function were compared between sulfonylurea,

sulfonylurea and biguanide combination and insulin, with the retrospective cohort

study design, on patients that use those agents in last four months and came to

out-patient clinic of RSK Dr. Sitanala Tangerang. This research had the Ethical

Clearance from the Ethical Committee of this hospital. Subjects were classify into

three groups, i.e insulin group (n = 30), sulfonylurea group (n = 30) and

sulfonylurea and biguanide combination group (n = 45). Hypoglycemic

effectiveness is measured with the HbA1C level and diabetic nephrophaty with

the eGFR which calculated from the measured serum creatinin. Mean age of all

subjects was 54,98±7,47 (p=0,157), most were women (72%, p=0,235), and tend

to overweight (mean BMI is 25,49±4,84; p = 0,59). Mean HbA1C level from the

sulfonylurea-biguanide (7,28±0,09) group were significantly different (p = 0,042)

with those from the insulin group (8,10±0,09), and there was no significant

difference with the sulfonylurea group. There was no significant difference in

diabetic nephropathy between groups. Subject with diabetic family history has

4,512 times chance to have the HbA1C level > 7% compare to those without

diabetic family history. Subjects with BMI >30 kg/m2 have 21,631 times chance

to get the HbA1C >7% compare to subjects with BMI <18,5 kg/m2. Sulfonylurea

and biguanide combination was more effective compare to insulin or sulfonylurea

monotherapy on decreasing HbA1C level of type 2 DM patients, without

significant difference in effect of lowering kidney functionH]"